英文名稱 Anti-CCL5/RANTES

中文名稱 T細(xì)胞特異性趨化因子抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來(lái)源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep

產(chǎn)品類(lèi)型 一抗

研究領(lǐng)域 腫瘤 免疫學(xué) 趨化因子

蛋白分子量 predicted molecular weight: 7.4/10kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCCL5 (62-91aa)

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 CCL5; TCP228; Small Inducible Cytokine A5; CCL5;SISd; MGC17164; SCYA5; RANTES; D17S136E; SIS-delta; chemokine (C-C motif)ligand 5; regulated on activation normal T cell expressed and secreted;chemokine (C-C motif) ligand 5; T-cell-specific protein RANTES; C-C motif chemokine5; EoCP; Eosinophil chemotactic cytokine; RANTES(3-68); RANTES(4-68);